APA (7th ed.) Citation

Johnson, J. R., Lossignol, D., Burnell-Nugent, M., & Fallon, M. T. (2012). An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics. Journal of pain and symptom management.

Chicago Style (17th ed.) Citation

Johnson, Jeremy R., Dominique Lossignol, Mary Burnell-Nugent, and Marie T. Fallon. "An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics." Journal of Pain and Symptom Management 2012.

MLA (9th ed.) Citation

Johnson, Jeremy R., et al. "An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics." Journal of Pain and Symptom Management, 2012.